Meldofsky Firm LLC Highlights the Studies of Health Canada on the Link of Developing Hepatic Injury to Xarelto Use
Xarelto or the Rivaroxaban which is one of what is said to be the latest and best alternative anticoagulant medication in the market today has been reviewed just recently by Health Canada in terms of its safety. However, the safety review summary released last August 26 this year investigated Xarelto in two separate studies and was found out to be linked in the development of liver injury in the 16 subjects. The purpose of the research conducted by the department...
View full press release